Inflammation (cycle modulation)

Inflammation is the immune system's response to perceived damage or threat. Acute inflammation is essential and short-lived; chronic low-grade inflammation is a driver of many long-term health conditions. Across the menstrual cycle, inflammatory markers cycle in a predictable pattern: relatively low in mid-cycle, rising through the late luteal phase, and peaking around menstruation when prostaglandin production drives uterine contractions.

The cyclic inflammation pattern explains several common cycle experiences (PMS, period pain, joint stiffness around menstruation) and modulates the timing of inflammatory flares in conditions like endometriosis, IBS, and migraine.

The inflammatory markers that cycle

Several markers have been shown to vary across the cycle:

C-reactive protein (CRP). General inflammation marker. Rises in late luteal and menstrual phase.
Interleukin-6 (IL-6). Pro-inflammatory cytokine. Increases late luteal.
Tumor necrosis factor alpha (TNF-α). Pro-inflammatory cytokine. Modest cyclic variation.
Prostaglandins. Locally produced in the uterus. Surge at menstruation onset; the main driver of cramps.
White blood cell counts. Modest cyclic variation.

The shifts are not dramatic in absolute terms. They are statistically significant and, layered onto baseline inflammation, can push borderline-symptomatic users into clearly symptomatic territory.

How hormones modulate inflammation

The two main drivers:

Estrogen. Generally anti-inflammatory. Higher estrogen suppresses cytokine production and supports immune regulation.
Progesterone. Mixed effects. Suppresses some inflammatory pathways while activating others. The withdrawal in late luteal is what matters most.

The cyclic pattern:

Early follicular (days 1 to 5): menstrual inflammation present (from prostaglandins). Hormones low.
Mid-to-late follicular (days 6 to 13): rising estrogen, declining inflammation. Often the lowest-inflammation week.
Ovulatory (days 14 to 16): estrogen peaks, inflammation low.
Early luteal (days 17 to 22): progesterone rising, inflammation moderate.
Late luteal (days 23 to 28): estrogen drops, progesterone drops. Inflammation rises.
Menstruation: prostaglandin surge in the uterus drives cramps and systemic inflammation peaks.

The pattern is consistent enough to explain why many users feel "puffy", "sluggish", or "achier" in the days before and during menstruation.

Prostaglandins and period pain

The most immediate cycle-related inflammation event is the prostaglandin surge at menstruation onset. As the endometrium breaks down, it releases prostaglandins (PGF2α and PGE2) that:

Contract uterine muscle to expel the lining. Strong contractions cause cramps.
Cause vasoconstriction, reducing oxygen delivery to uterine tissue, contributing to pain.
Stimulate gut motility, which can cause loose stools and nausea.
Drive systemic effects, including headache and lower back pain.

This is why NSAIDs (ibuprofen, naproxen) work for period pain: they block prostaglandin synthesis. Taken 24 to 48 hours before pain starts, they reduce prostaglandin production preemptively rather than fighting an established surge.

Dysmenorrhea (clinically significant period pain) involves abnormally high prostaglandin production or sensitivity.

Cyclic flares in inflammatory conditions

The inflammation pattern modulates several conditions:

Endometriosis. Inflammatory lesions flare in late luteal and menstrual phase. Pain peaks predictably.
Cyclical IBS. Gut inflammation and motility shift across the cycle, with symptoms peaking late luteal and early menstrual.
Menstrual migraine. Linked to estrogen withdrawal and the prostaglandin/inflammation surge.
Joint conditions. Some users with rheumatoid arthritis or fibromyalgia report cycle-related symptom variation.
Autoimmune conditions. Estrogen's immune-modulating effects can produce cyclic shifts in symptom severity.
Asthma. "Premenstrual asthma" is a documented pattern, with symptoms worsening late luteal in a subset of users.

The cyclic flare pattern is useful diagnostic information. If symptoms reliably worsen at the same cycle point, that suggests a hormonal modulation worth investigating.

Inflammation, PMS, and cravings

Inflammation is part of the PMS picture, alongside serotonin, GABA, and dopamine cycling. Some PMS symptoms (bloating, joint achiness, headache, brain fog) map onto inflammation rather than mood neurotransmitters directly. This is part of why anti-inflammatory dietary patterns (more omega-3, fewer ultra-processed foods) sometimes help PMS, and why omega-3 in PMS has supportive evidence.

Practical anti-inflammatory levers

The reliable levers, in rough order of evidence:

Omega-3 fatty acids. Modest evidence for cycle-related symptom reduction. Two to three servings of fatty fish per week, or 1 to 3 g EPA+DHA supplementation.
NSAIDs for period pain. Most direct intervention. Start 24 to 48 hours before pain typically begins.
Aerobic exercise. Chronic anti-inflammatory effect.
Sleep. Sleep loss is pro-inflammatory.
Reduce ultra-processed foods. Modest evidence for inflammation reduction.
Magnesium. Some evidence for cramp reduction; see magnesium PMS.

For users with significant inflammatory cycle conditions (endometriosis, severe dysmenorrhea), a more aggressive medical approach is warranted, not just lifestyle adjustments.

Dysmenorrhea: the clinical term for significant period pain
Endometriosis: chronic inflammatory cycle condition
Omega-3 in PMS: anti-inflammatory supplementation evidence
PMS: the broader premenstrual symptom cluster